摘要 |
<p>The instant invention relates to a combination, particularly a synergistic combination, of an alpha-2-delta ligand and a dual serotonin-noradrenaline re-uptake inhibitor (DSNRI) or one or both of a selective serotonin re-uptake inhibitor (S SRI) and a selective noradrenaline re-uptake inhibitor (SNRI), and pharmaceutically acceptable salths thereof, pharmaceutical compositions thereof and their use in the treatment of pain, particularly neuropathic pain.</p> |
申请人 |
PFIZER LIMITED;DOOLEY, DAVID, J.;FIELD, MARK, JOHN;WILLIAMS, RICHARD, GRIFFITH;PFIZER INC. |
发明人 |
DOOLEY, DAVID, J.;FIELD, MARK, JOHN;WILLIAMS, RICHARD, GRIFFITH |